Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 1/20 | 0.52 |
| ▸ | ACACB | O00763 | 1/20 | 0.41 |
| ▸ | ACACA | Q13085 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 5/20 | 0.37 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2894770 | 0.88 | ACLY (0.61) | ACLYACACBACACAPPARAABCC4 | |
| SCHEMBL4647923 | 0.85 | ACLY (0.68) | ACLYACACBACACAPPARAABCC4 | |
| SCHEMBL15261097 | 0.83 | ACLY (0.71) | ACLYACACBACACAPPARAABCC4 | |
| SCHEMBL3111881 | 0.83 | ACLY (0.71) | ACLYACACBACACAPPARAABCC4 | |
| SCHEMBL2212000 | 0.83 | ACLY (0.71) | ACLYACACBACACAPPARAABCC4 | |
| SCHEMBL10172300 | 0.81 | ALOX15 (0.34) | ACLYABCC4MAPTTSHRALDH1A1 | |
| SCHEMBL6059309 | 0.81 | TET2 (0.45) | ACLYABCC4MAPTTSHRALDH1A1 | |
| SCHEMBL8385882 | 0.81 | ACLY (0.38) | ACLYABCC4MAPTTSHRALDH1A1 | |
| SCHEMBL38658267 | 0.79 | ACLY (0.32) | ACLYABCC4MAPTTSHRALDH1A1 | |
| SCHEMBL1012581 | 0.78 | ACLY (0.54) | ACLYACACBACACAPPARATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503422-B2 | Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor | NEUROBO PHARMACEUTICALS, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| EP-3702381-B1 | COPOLYMER OF OLEFIN AND UNSATURATED CARBOXYLIC ACID OR UNSATURATED CARBOXYLIC ACID DERIVATIVE | CHINA PETROLEUM & CHEM CORP (CN) | 2025-12-03 | — | — | EP | disclosed |
| US-12473387-B2 | Copolymer of olefin and unsaturated carboxylic acid or unsaturated carboxylic acid derivative | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2025-11-18 | — | — | US | disclosed |
| US-20250320238-A1 | TRANSITION METAL CLUSTER COMPOUND, PHOTOSENSITIVE COMPOSITION, PATTERN FORMING METHOD, AND METHOD FOR PRODUCING SUBSTRATE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-10-16 | — | — | US | disclosed |
| US-12428505-B2 | Method for preparing olefin-polar monomer copolymer | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2025-09-30 | — | — | US | disclosed |
| WO-2024142879-A1 | TRANSITION METAL CLUSTER COMPOUND, PHOTOSENSITIVE COMPOSITION, PATTERN FORMATION METHOD, AND METHOD FOR PRODUCING CIRCUIT BOARD | 三菱ケミカル株式会社 | 2024-07-04 | — | — | WO | disclosed |
| US-11834482-B2 | Agents modulating beta-catenin functions and methods thereof | FOG PHARMACEUTICALS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230357320-A1 | HELICAL STAPLED PEPTIDES AND USES THEREOF | PARABILIS MEDICINES, INC. | 2023-11-09 | — | — | US | disclosed |
| US-20230257499-A1 | COPOLYMER OF OLEFIN AND UNSATURATED CARBOXYLIC ACID OR UNSATURATED CARBOXYLIC ACID DERIVATIVE | BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-08-17 | — | — | US | disclosed |
| CN-116284527-A | Ultrahigh molecular weight polyolefin and preparation method thereof | 中国石油化工股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2009033069-A1 | SIMPLE PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| WO-2009033054-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| WO-2009033061-A1 | MASKED CARBOXYLATE NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| US-20090069419-A1 | MASKED CARBOXYLATE NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2006069096-A1 | SILANOL DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE | PHARMACYCLICS, INC. (US) | 2006-06-29 | — | — | WO | disclosed |
| US-7038064-B2 | Process for producing hydroxylactones | DIACEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-05-02 | — | — | US | disclosed |
| EP-1302469-B1 | PROCESS FOR PRODUCING HYDROXYLACTONE | DAICEL CHEM (JP) | 2005-03-30 | — | — | EP | disclosed |
| US-20040024228-A1 | Process for producing hydroxylactones | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-02-05 | — | — | US | disclosed |
| EP-1302469-A1 | PROCESS FOR PRODUCING HYDROXYLACTONE | Daicel Chemical Industries, Ltd. (JP) | 2003-04-16 | — | — | EP | disclosed |
| US-4311618-A | Cleanser with ionic and nonionic surfactants | SCHAEFER BURKHARD WERNER | 1982-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357320-A1 | HELICAL STAPLED PEPTIDES AND USES THEREOF | ESRRB, ESR1, ESRRA | ACLY 2752/4885ACACB 4069/4885ACACA 4127/4885 |
| US-20090069419-A1 | MASKED CARBOXYLATE NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | ADSL, AASDHPPT, ACMSD | ACLY 395/4885ACACB 301/4885ACACA 207/4885 |
| US-12503422-B2 | Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor | NPC1L1, NOTUM, CEL | ACLY 2298/4885ACACB 1237/4885ACACA 1161/4885 |
| US-20040024228-A1 | Process for producing hydroxylactones | HAO2, HAO1, DUOX2 | ACLY 1432/4885ACACB 1067/4885ACACA 763/4885 |
| US-20250320238-A1 | TRANSITION METAL CLUSTER COMPOUND, PHOTOSENSITIVE COMPOSITION, PATTERN FORMING METHOD, AND METHOD FOR PRODUCING SUBSTRATE | TYR, MITF, TRPA1 | ACLY 1522/4885ACACB 2563/4885ACACA 2144/4885 |
| US-11834482-B2 | Agents modulating beta-catenin functions and methods thereof | CTNNB1, CTNNBL1, CTNNA1 | ACLY 3601/4885ACACB 2211/4885ACACA 2032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.